The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Summarizing indices for comparison of cancer incidence data
Abstract
The desirability of achieving agreement on a method of summarizing cancer incidence is emphasized, and the advantages and disadvantages of the use of the traditional standardized incidence rates are discussed. It is concluded that: No single index is capable of replacing the individual sex‐ and age‐specific incidence rates, and these should always be presented when basic cancer incidence data are published. For aetiological studies age‐specific incidence rates can usefully be summarized in two indices, one (a truncated standardized incidence) showing a standardized incidence over a restricted age range, and the other indicating the rate at which cancer incidence increases with age. An appropriate truncated rate for most epithelial cancers is one for the age range of 35 to 64 years, using weights of 6, 6, 6, 5, 4 and 4 for the individual 5‐year age groups, derived from Segi's (1960) world standard population. For other cancers, age ranges of 0 to 14 years and of 0 to 44 years would be more suitable, with weights of 12, 10 and 9, and 12, 10, 9, 9, 8, 8, 6, 6 and 6 for the corresponding 5‐year age groups. An indication of the general character of a given set of incidence data may be obtained by calculating the ratio of the rates at ages 55 to 64 years and at 35 to 44 years for a combined group of cancers that normally increase rapidly in incidence with age. Further research on practicable ways of indicating the shape of the age‐incidence curve for individual types of cancer is required.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cancer Incidence in Five Continents
(1966) · doi:10.1007/978-3-642-85849-9 · Cited by 5,936
Cancer mortality for selected sites in 24 countries
栗原, 登., & 瀬木, 三. (1960) · Medical Entomology and Zoology · Cited by 871
Cited by
Global cancer statistics, 2012
Torre, L. A., Bray, F., Siegel, R. L., Ferlay, J., Lortet‐Tieulent, J., & Jemal, A. (2015) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21262 · Cited by 26,850
Cancer statistics in China, 2015
Chen, W., Zheng, R., Baade, P. D., Zhang, S., Zeng, H., Bray, F., Jemal, A., Yu, X. Q., & He, J. (2016) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21338 · Cited by 17,038
Global Cancer Incidence and Mortality Rates and Trends—An Update
Torre, L. A., Siegel, R. L., Ward, E. M., & Jemal, A. (2016) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-15-0578 · Cited by 3,692
Armstrong, B., & Doll, R. (1975) · International Journal of Cancer · doi:10.1002/ijc.2910150411 · Cited by 2,151
Self-citationGlobal cancer in women: burden and trends.
Torre, L. A., Islami, F., Siegel, R. L., Ward, E. M., & Jemal, A. (2017) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-16-0858 · Cited by 1,245
Global patterns and trends in colorectal cancer incidence in young adults
Siegel, R. L., Torre, L. A., Soerjomataram, I., Hayes, R. B., Bray, F., Weber, T. K., & Jemal, A. (2019) · Gut · doi:10.1136/gutjnl-2019-319511 · Cited by 925
Global burden and trends in premenopausal and postmenopausal breast cancer: a population-based study
Heer, E., Harper, A., Escandor, N., Sung, H., McCormack, V., & Fidler-Benaoudia, M. M. (2020) · The Lancet Global Health · doi:10.1016/s2214-109x(20)30215-1 · Cited by 888
Increasing Incidence of Testicular Cancer Worldwide: A Review
HUYGHE, E., MATSUDA, T., & THONNEAU, P. (2003) · Journal of Urology · doi:10.1097/01.ju.0000053866.68623.da · Cited by 605
NORDCAN – a Nordic tool for cancer information, planning, quality control and research
Engholm, G., Ferlay, J., Christensen, N., Bray, F., Gjerstorff, M. L., Klint, Å., Køtlum, J. E., Ólafsdóttir, E., Pukkala, E., & Storm, H. H. (2010) · Acta Oncologica · doi:10.3109/02841861003782017 · Cited by 537
Global burden and trends of lung cancer incidence and mortality
Li, C., Lei, S., Ding, L., Xu, Y., Wu, X., Wang, H., Zhang, Z., Gao, T., Zhang, Y., & Li, L. (2023) · Chinese Medical Journal · doi:10.1097/cm9.0000000000002529 · Cited by 441
Kerkhofs, T. M. A., Verhoeven, R. H. A., Van der Zwan, J. M., Dieleman, J., Kerstens, M. N., Links, T. P., Van de Poll-Franse, L. V., & Haak, H. R. (2013) · European Journal of Cancer · doi:10.1016/j.ejca.2013.02.034 · Cited by 341
Global trends in esophageal cancer
Malhotra, G. K., Yanala, U., Ravipati, A., Follet, M., Vijayakumar, M., & Are, C. (2017) · Journal of Surgical Oncology · doi:10.1002/jso.24592 · Cited by 324
Prostate cancer incidence and mortality trends in 37 European countries: An overview
Bray, F., Lortet-Tieulent, J., Ferlay, J., Forman, D., & Auvinen, A. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2010.09.013 · Cited by 307
Simard, E. P., Torre, L. A., & Jemal, A. (2014) · Oral Oncology · doi:10.1016/j.oraloncology.2014.01.016 · Cited by 304
Stocks, T., Van Hemelrijck, M., Manjer, J., Bjørge, T., Ulmer, H., Hallmans, G., Lindkvist, B., Selmer, R., Nagel, G., Tretli, S., et al. (2012) · Hypertension · doi:10.1161/hypertensionaha.111.189258 · Cited by 286
Incidence and survival of malignant bone sarcomas in England 1979–2007
Whelan, J., McTiernan, A., Cooper, N., Wong, Y. K., Francis, M., Vernon, S., & Strauss, S. J. (2012) · International Journal of Cancer · doi:10.1002/ijc.26426 · Cited by 255
Cancer burden in China: trends, risk factors and prevention
Sun, D., Li, H., Cao, M., He, S., Lei, L., Peng, J., & Chen, W. (2020) · Cancer Biology and Medicine · doi:10.20892/j.issn.2095-3941.2020.0387 · Cited by 255
Barone-Adesi, F., Vizzini, L., Merletti, F., & Richiardi, L. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehl201 · Cited by 240
“First, we found that the decrease in admission rates was limited to persons under 60, consistent with Table 1 Numbers of admissions for AMI and age-standardized rates (cases/1000 person-years) by year and age group (Piedmont, Italy, 2001–2005) Age (years) Sex February–June 2001 February–June 2002 February–June 2003 Fe…”
MethodInfluential
Metadata
- Authors
- Doll, R., & Cook, P.
- Venue
- International Journal of Cancer
- Publisher
- Wiley
- Published
- 1967-05-15
- Volume
- 2
- Issue
- 3
- Pages
- 269-279
- ISSN
- 0020-7136 (ISSN-L)
- 1097-0215
- OpenAlex
- W1998264374
- Cited by
- 289
- References
- 2
- FWCI
- 1.23
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.